Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2019

Jul 8, 2019

34491_dirs_2019-07-08_4eff0284-0fe7-46e6-9631-585200d3ad09.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-07-04

Reporting Person: Scimeca Dario (General Counsel)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-04 Stock Option (Right to Buy) $13.39 A 160000 Acquired 2029-07-03 Common Stock (160000) Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on June 10, 2020 and as to 6.25% of the underlying shares at the end of each successive three-month period until June 10, 2023.